Closing Bell: Nervgen Pharma Corp up on Friday (NGEN)

In today's trading, Nervgen Pharma Corp shares closed at $3.26 after opening the day at $3.23. Intraday prices ranged from $3.15 to $3.30.

Share prices advanced 1.87 percent from the previous day's close of $3.20.

During the day across North America, the TSX Composite closed -0.83% at 22059.03, the S&P 500 closed 0.51% at 5537.02, the Dow Jones Industrial Average closed -0.06% at 39308.00 and the Nasdaq Composite closed nasdaq_percentage_change% at 18188.30.

Nervgen Pharma Corp traded under NGEN on the Toronto Venture Exchange (TSX-V).

Trading volume was 107,801 on 280 total trades, while having an average volume of 103,473 in the last five days.

The TSX-V overall saw 2,018 price advancers against 3,199 declines and 106 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, in the last 12 months, Nervgen Pharma Corp's shares have risen 100.00%, while they have boosted 20.74% since the start of 2024.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $223.77 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Nervgen Pharma Corp has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..